Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement

Sponsor
Sun Yat-sen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT02814149
Collaborator
(none)
40
1
2
133
0.3

Study Details

Study Description

Brief Summary

The aim of this prospective cohort study is to compare the esthetic, clinical and patient-centered outcomes following immediate and delayed implant placement protocols.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Type 1 implant placement
  • Procedure: Type 3 implant placement
N/A

Detailed Description

Patients are divided into two groups: immediate and delayed implant placement. The investigators are asking subjects to take part in a research study of soft tissue and bone healing around dental implants following tooth extraction. The investigators want to compare how the gums and the bone changes shape with healing in two different scenarios.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Esthetic, Clinical and Radiographic Outcomes of Immediate Implant Placement and Delayed Implant Placement in the Anterior Region of the Maxilla
Actual Study Start Date :
May 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2026
Anticipated Study Completion Date :
Jun 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Type 1 implant placement

Implant is placed immediately following tooth extraction in one surgical procedure

Procedure: Type 1 implant placement
Implant is placed immediately following tooth extraction in one surgical procedure
Other Names:
  • Immediate implant placement
  • Active Comparator: Type 3 implant placement

    Implant is placed in the site which is left to heal for 3 months following tooth extraction

    Procedure: Type 3 implant placement
    Implant is placed in the site which is left to heal for 3 months following tooth extraction
    Other Names:
  • Delayed implant placement
  • Outcome Measures

    Primary Outcome Measures

    1. Pink and white esthetic scores (PES/WES) [Up to 10 years after baseline]

      Baseline will be at the time of implant placement.Pink and white esthetic scores (PES/WES) will be recorded at 0.5, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    2. Radiographic bone volume [Up to 10 years after baseline]

      Radiographic bone volume be assessed at pre-operation, 0 ,1.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    Secondary Outcome Measures

    1. Implant survival [Up to 10 years after baseline]

      Implant survival will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    2. Probing depth [Up to 10 years after baseline]

      Probing depth will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    3. Modified plaque index [Up to 10 years after baseline]

      Modified plaque index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    4. Modified bleeding index [Up to 10 years after baseline]

      Modified bleeding index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    5. Buccal marginal recession [Up to 10 years after baseline]

      Buccal marginal recession will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    6. Papilla volume [Up to 10 years after baseline]

      Papilla volume will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    7. Width of keratinized gingiva [Up to 10 years after baseline]

      Width of keratinized gingiva will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    8. Visual analogue scale (VAS) [Up to 10 years after baseline]

      A questionnaire will be recorded at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    9. Oral health impact profile shortened version (OHIP-I) [Up to 10 years after baseline]

      A questionnaire will be recorded at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • At least 18 years old and able to understand an informed consent

    • Adequate oral hygiene to allow for implant therapy consistent with standards of care.

    • Missing a single tooth in the maxillary anterior region

    • Presence of adjacent natural teeth

    Exclusion Criteria:
    • Poor oral hygiene

    • Severe parafunctional habits, for example, bruxing and clenching

    • Presence of clinically active periodontal disease as expressed by probing pocket depths≄4 mm in combination with bleeding on probing.

    • Conditions that might lead to a possibly lowered regenerative capacity of the bone, for example, osteoporosis and Paget's disease

    • Pregnant or expecting to be pregnant

    • History of drug and alcohol abuse

    • History of systemic diseases that would contraindicate oral surgical treatment, for example, uncontrolled diabetes (defined as HBA1c level >7%)

    • Radiotherapy in the head and neck area,

    • On certain medications like bisphosphonates or steroids currently or within the past three months

    • Absence of adjacent teeth

    • Unwillingness to return for the follow-up examination

    • Smokers (more than 20 cigarettes per day). Subjects smoking <20 cigarettes per day were requested to stop smoking before and after surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Guanghua School of Stomatology Hospital of Stomatology Guangzhou Guangdong China 510000

    Sponsors and Collaborators

    • Sun Yat-sen University

    Investigators

    • Study Director: Zhuofan Chen, Sun Yat-sen University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Xin Liu, post graduate, Sun Yat-sen University
    ClinicalTrials.gov Identifier:
    NCT02814149
    Other Study ID Numbers:
    • XinL
    First Posted:
    Jun 27, 2016
    Last Update Posted:
    Nov 1, 2019
    Last Verified:
    Oct 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Xin Liu, post graduate, Sun Yat-sen University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 1, 2019